Biotech · Private company · East Lansing, MI, US
Tarn Biosciences, Inc.
Track this companyFree. Adds Tarn Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Development of nitroreductase-activated inhibitors to treat mycobacterial infectionsFiscal year 2026 · $287.9KNIH RePORTER 5R41AI194849-02 · fetched Nov 12, 2026
- Development of nitroreductase-activated inhibitors to treat mycobacterial infectionsFiscal year 2025 · $298.8KNIH RePORTER 1R41AI194849-01 · fetched Nov 12, 2026
- Development of the HC2099 series of MmpL3 inhibitors to treat tuberculosisFiscal year 2024 · $293.2KNIH RePORTER 5R41AI167105-02 · fetched Nov 12, 2026